Combination therapy, when combined, represents a major progress in the field of cancer treatment.non-small cell lung cancer (NSCLC) with EGFR mutations has been effectively treated with osimertinib, a third-generation EGFR inhibitor.Attention has been gained by adaura, a plant extract with potent anti-inflammatory effects, for its potential to enhance the treatment outcomes of cancer treatments.This article investigates the synergistic properties of Combination therapy, identifying the unaddressed challenges in the field of cancer treatment and delving into their future applications.boosting antitumor effect is held out as great promise by the combination of…
